Tango Therapeutics, Inc.
TNGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $15,884 | -$38,853 | -$39,876 | -$37,670 |
| Dep. & Amort. | $555 | $625 | $622 | $620 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $6,570 | $7,255 | $7,462 |
| Change in WC | -$54,428 | -$5,156 | -$10,016 | -$7,147 |
| Other Non-Cash | $7,037 | $295 | $318 | $88 |
| Operating Cash Flow | -$30,952 | -$36,519 | -$41,697 | -$36,647 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$151 | -$624 | -$51 | -$124 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$18,337 | -$23,936 | -$47,164 | -$32,549 |
| Inv. Sales/Matur. | $65,965 | $41,338 | $77,812 | $84,733 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $47,477 | $16,778 | $30,597 | $52,060 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,541 | $581 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $2 | $969 |
| Financing Cash Flow | $2,541 | $581 | $2 | $969 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $19,066 | -$19,160 | -$11,098 | $16,382 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39,700 | $60,999 | $72,097 | $55,715 |
| End Cash | $58,766 | $41,839 | $60,999 | $72,097 |
| Free Cash Flow | -$31,103 | -$37,143 | -$41,748 | -$36,771 |